Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s Disease: A Review from Pathophysiology to Treatment
Bianca L. B. Marino, Lucilene Rocha de Souza, Kessia P.A. Sousa, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 20, Iss. 9, pp. 754-767
Closed Access | Times Cited: 169

Showing 51-75 of 169 citing articles:

Rescuing a Troubled Tolcapone with PEGylated PLGA Nanoparticles: Design, Characterization, and Hepatotoxicity Evaluation
Miguel Pinto, Cláudia Sofia Machado, Sandra Barreiro, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 17, pp. 21522-21533
Closed Access | Times Cited: 3
Pomegranate (Punica granatum L.) Extract Effects on Inflammaging
Raffaele Cordiano, Luca Gammeri, Eleonora Di Salvo, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4174-4174
Open Access | Times Cited: 3
Formononetin Exerts Neuroprotection in Parkinson’s Disease via the Activation of the Nrf2 Signaling Pathway
Xiaotong Wang, Nianxin Kang, Ying Liu, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5364-5364
Open Access | Times Cited: 3
Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model
Wei Ni, Jiqin Zhou, Yating Ling, et al.
Brain Research (2022) Vol. 1790, pp. 147978-147978
Closed Access | Times Cited: 15
Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models
Mohamad Ayajuddin, Limamanen Phom, Zevelou Koza, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 14
Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 8
Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy
Aruna Sharma, Dafin F. Mureşanu, Ranjana Patnaik, et al.
Progress in brain research (2021), pp. e1-e2
Closed Access | Times Cited: 20
Three-dimensional neuroimmune co-culture system for modeling Parkinson’s disease microenvironments in vitro
Laura Rueda-Gensini, Julian A. Serna, D. Rodríguez Rubio, et al.
Biofabrication (2023) Vol. 15, Iss. 4, pp. 045001-045001
Open Access | Times Cited: 7
Investigating gait-responsive somatosensory cueing from a wearable device to improve walking in Parkinson’s disease
Dongli Li, Andre Hallack, Sophie Gwilym, et al.
BioMedical Engineering OnLine (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson’s Disease
Katie K. N. Tran, Vickie Wong, Kirstan A. Vessey, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
Efthalia Angelopoulou, Anastasia Bougea, Yam Nath Paudel, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1138-1138
Open Access | Times Cited: 6
Aerobic exercise modulates the striatal Erk/MAPK signaling pathway and improves LID in a mouse model of Parkinson's disease
Fangyuan Zhou, Longwei Wei, Yinhao Wang, et al.
Brain Research Bulletin (2024) Vol. 209, pp. 110906-110906
Open Access | Times Cited: 2
Current and further outlook on the protective potential of Antrodia camphorata against neurological disorders
Weiling Li, Pin Wan, Jialu Qiao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
NIR-II light therapy improves cognitive performance in MPTP induced Parkinson's disease rat models: A preliminary experimental study
Jiangong Zhang, Qinqin Zhu, Xun Shi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32800-e32800
Open Access | Times Cited: 2
Current progress in aptamer-based sensors for the detection of protein biomarkers in neurodegenerative diseases
Tao Cheng, Noshin Afshan, Jianwei Jiao, et al.
Biosensors and Bioelectronics X (2024) Vol. 20, pp. 100528-100528
Open Access | Times Cited: 2
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis
Wei Quan, Jia Li, Xiya Jin, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 15
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia
Natasha Irrera, María Antonietta Barbieri, Gianluca Bagnato, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 21, Iss. 10, pp. 1017-1026
Closed Access | Times Cited: 10
Low-Field Magnetic Stimulation Alleviates MPTP-Induced Alterations in Motor Function and Dopaminergic Neurons in Male Mice
Sathiya Sekar, Yanbo Zhang, Hajar Miranzadeh Mahabadi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10328-10328
Open Access | Times Cited: 6
Network pharmacology analysis of the active ingredients of Corydalis hendersonii Hemsl. and their effects on eliminating neuroinflammation and improving motor functions in MPTP-intoxicated mice
Jun Wang, Qiu-Tong Liu, Dan-Yang Shen, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 117009-117009
Closed Access | Times Cited: 6
2-Methoxyestradiol and Hydrogen Peroxide as Promising Biomarkers in Parkinson’s Disease
Paulina Bastian, Lucyna Konieczna, Jarosław Dulski, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 148-166
Open Access | Times Cited: 6
Neuroprotective potential of Cordia dichotoma in Parkinson's syndrome induced by haloperidol: An animal study
K. Durga Bhavani, A. Muthukumar, Mansour Almuqbil, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 10, pp. 101791-101791
Open Access | Times Cited: 6
Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson’s Disease
Wei Quan, Jia Li, Li Liu, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 14
Title of the manuscript: Mechanistic insights into chalcone butein-induced inhibition of α-synuclein fibrillation: Biophysical and insilico studies
Tinku, Harshad Paithankar, Ankita R. Rane, et al.
Journal of Molecular Liquids (2021) Vol. 334, pp. 116105-116105
Closed Access | Times Cited: 13
A Research Update on Exendin-4 as a Novel Molecule Against Parkinson’s Disease
Niraj Kumar Singh, Ashini Singh, M. Varshney, et al.
Current Molecular Medicine (2023) Vol. 23, Iss. 9, pp. 889-900
Closed Access | Times Cited: 5
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
Frédéric Checler, Cristine Alvès da Costa
Biomolecules (2022) Vol. 12, Iss. 4, pp. 559-559
Open Access | Times Cited: 8

Scroll to top